- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07822126
Accurate Planning and Guidance of Bronchoscopy for Lung Cancer Management
The main objective of this project is to demonstrate the potential of three new technical innovations for improving state-of-the-art bronchoscopy guidance systems.
Through this study, we plan to generate preliminary data that demonstrates the potential of three new innovations for enhancing existing bronchoscopy systems in the live clinical setting.
The goal is to demonstrate the potential of the new innovations: 1. to demonstrate the potential of a new methodology to reduce errors from CT-to-body divergence in the live clinical setting, 2. to demonstrate the potential of the new methodologies to enable live rerouting of a guided bronchoscopy, and 3. to perform automatic real-time mucosal lesion detection during a standard airway examination.
These innovations could potentially improve current image-guided bronchoscopy systems and be used for future robotic bronchoscopy.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: William E Higgins, PhD
- Número de teléfono: 814-865-0186
- Correo electrónico: weh2@psu.edu
Copia de seguridad de contactos de estudio
- Nombre: Rebecca Bascom, MD, MPH
- Número de teléfono: 717-531-2925
- Correo electrónico: rbascom@pennstatehealth.psu.edu
Ubicaciones de estudio
-
-
Pennsylvania
-
Hershey, Pennsylvania, Estados Unidos, 17033
- Penn State Milton S. Hershey Medical Center
-
Contacto:
- Timothy P Sheehan, MS
- Número de teléfono: 284024 717-531-0003
- Correo electrónico: tsheehan@pennstatehealth.psu.edu
-
Sub-Investigador:
- Rebecca Bascom, MD, MPH
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- a planned clinical bronchoscopy to evaluate abnormal lung parenchyma and/or central chest lymph nodes;
Radiology images, previously obtained for clinical purposes, that meet technical specifications and are available on our team's Radiology research server or can be uploaded from the Hershey Medical Center clinical image storage system.
- a clinical CT scan performed at Hershey Medical Center, AND
- Either one of two additional clinically available scans:
- CT/PET study OR
- a clinical CT scan that includes inspiratory and expiratory images
- Must be able to read, write, and speak English.
Exclusion Criteria:
- Special classes of subjects that will be excluded are pregnant women because clinical CT scans and CT/PET studies are avoided because of the potential for radiation injury to the fetus.
- Mentally incompetent subjects will be excluded. They will be identified as such because their treating clinician will have deemed them unable to provide consent for their clinical procedure. The clinical record will indicate whether the patient is providing consent or a surrogate decision-maker has been needed. Patients with a surrogate decision-maker will be excluded.
- We will exclude prisoners and institutionalized individuals because their autonomy is compromised by their status, and the study provides no direct benefit from which they would be excluded. Individuals who become prisoners or are institutionalized after giving consent but before their diagnostic procedure would also be excluded. Their clinical record will identify if they are in custody.
- Children are not part of this project because they do not get lung cancer. Therefore, we do not provide processes for meeting requirements for parental permission and child assent.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Consented Clinical Bronchoscopy Cohort
Lung cancer patients, scheduled for bronchoscopy, who are consented for bronchoscopy by the Virtual Navigator.
|
The Virtual Navigator guidance computer is interfaced to the bronchoscopy hardware to tap off the live bronchoscopy video feed.
The standard OR medical team (technicians, clinical fellows, et al.) is on hand, and standard clinical facilities (e.g., fluoroscopy, CT/PET image viewer) are available.
Our technical team is also present to record all procedural video and computer display information.
It also operates the guidance computer during the guided procedure and offers any assistance in case of unanticipated issues.
The participant's clinical bronchoscopy will be recorded by the radiology imaging management system.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Functionality of CTBD Compensation
Periodo de tiempo: 15 minutes
|
Establish the functionality of the CTBD compensation methodology during a live guided bronchoscopy to a preselected ROI.
|
15 minutes
|
|
Procedure time of CTBD Compensation
Periodo de tiempo: 15 minutes
|
Total live procedure time taken to complete bronchoscope navigation to the ROI.
|
15 minutes
|
|
Functionality of Rerouting Methodology
Periodo de tiempo: 15 minutes
|
Functionality of the rerouting methodology during a live guided bronchoscopy to a preselected ROI for the situation that an airway branch along the preplanned airway route to the ROI is unnavigable.
|
15 minutes
|
|
Procedure time of Rerouting Methodology
Periodo de tiempo: 15 minutes
|
Total live procedure time taken to complete bronchoscope navigation to the ROI, including rerouting.
|
15 minutes
|
|
Functionality of Rerouting to a new ROI
Periodo de tiempo: 15 minutes
|
Functionality of the rerouting methodology during a live guided bronchoscopy to a preselected ROI for the situation where the system is rerouted to a new ROI during navigation.
|
15 minutes
|
|
Procedure time of Rerouting Methodology to a new ROI
Periodo de tiempo: 15 minutes
|
Total live procedure time taken to complete bronchoscope navigation to a preselected ROI, including rerouting to a new ROI during navigation.
|
15 minutes
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: William E Higgins, PhD, Penn State University
- Director de estudio: Rebecca Bascom, MD, MPH, Milton S. Hershey Medical Center
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 28052
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .